The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia

Bifidobacteria colonize the human gastrointestinal tract early on in life, their interaction with the host starting soon after birth. The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, irritable bowel syndrome,...

Full description

Bibliographic Details
Main Authors: Luisa Marras, Michele Caputo, Sonia Bisicchia, Matteo Soato, Giacomo Bertolino, Susanna Vaccaro, Rosanna Inturri
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/9/4/836
_version_ 1827695169355382784
author Luisa Marras
Michele Caputo
Sonia Bisicchia
Matteo Soato
Giacomo Bertolino
Susanna Vaccaro
Rosanna Inturri
author_facet Luisa Marras
Michele Caputo
Sonia Bisicchia
Matteo Soato
Giacomo Bertolino
Susanna Vaccaro
Rosanna Inturri
author_sort Luisa Marras
collection DOAJ
description Bifidobacteria colonize the human gastrointestinal tract early on in life, their interaction with the host starting soon after birth. The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, irritable bowel syndrome, eczema or atopic dermatitis, and asthma. Non-replicative strains of <i>Bifidobacterium longum</i> (NCC3001 and NCC2705) promote the differentiation of normal human epidermal keratinocytes (NHEKs), inducing a high expression of differentiation markers (keratin —KRT1—, and transglutaminase —TGM1—) and pro-regeneration markers (cathepsins), including β-defensin-1, which plays an important role in modulating the cutaneous immune response. Strains belonging to the genera <i>Bifidobacterium</i> and <i>Lactobacillus</i> can increase tight-junction proteins in NHEKs and enhance barrier function. Bifidobacteria and lactobacilli may be used as prophylactic or therapeutic agents towards enteric pathogens, antibiotic-associated diarrhea, lactose intolerance, ulcerative colitis, irritable bowel syndrome, colorectal cancer, cholesterol reduction, and control of obesity and metabolic disorders. <i>Bifidobacterium bifidum</i> showed an in vitro capability of lowering cholesterol levels thanks to its absorption into the bacterial membrane. Several strains of the species <i>Lactobacillus acidophilus</i>, <i>L. delbrueckii</i> subsp. <i>bulgaricus</i>, <i>L. casei</i>, and <i>L. gasseri</i> led to a reduced amount of serum cholesterol due to their ability to assimilate cholesterol (in vitro). <i>Lactococcus lactis</i> KF147 and <i>Lactobacillus plantarum</i> Lp81 have also been shown to reduce cholesterol levels by 12%. Clarifying the specific health mechanisms of <i>Bifidobacterium</i> and <i>Lactobacillus</i> strains in preventing high-cost pathologies could be useful for delineating effective guidelines for the treatment of infants and adults.
first_indexed 2024-03-10T12:20:45Z
format Article
id doaj.art-eaa9c2f4fb77433db59179c9277cfb3e
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-10T12:20:45Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-eaa9c2f4fb77433db59179c9277cfb3e2023-11-21T15:34:34ZengMDPI AGMicroorganisms2076-26072021-04-019483610.3390/microorganisms9040836The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and HypercholesterolemiaLuisa Marras0Michele Caputo1Sonia Bisicchia2Matteo Soato3Giacomo Bertolino4Susanna Vaccaro5Rosanna Inturri6Department of Medical Science and Public Health, University of Cagliari, 09042 Cagliari, ItalyFidia Farmaceutici S.p.A., R&D Unità locale Fidia Research sud, Contrada Pizzuta, 96017 Noto, ItalyFidia Farmaceutici S.p.A., R&D Unità locale Fidia Research sud, Contrada Pizzuta, 96017 Noto, ItalyFidia Farmaceutici S.p.A., R&D Abano Terme, 35031 Abano Terme, ItalyPharmaceutical Department, Azienda Ospedaliero Universitaria di Cagliari, 09042 Cagliari, ItalyFidia Farmaceutici S.p.A., R&D Unità locale Fidia Research sud, Contrada Pizzuta, 96017 Noto, ItalyFidia Farmaceutici S.p.A., R&D Unità locale Fidia Research sud, Contrada Pizzuta, 96017 Noto, ItalyBifidobacteria colonize the human gastrointestinal tract early on in life, their interaction with the host starting soon after birth. The health benefits are strain specific and could be due to the produced polysaccharides. The consumption of probiotics may prevent obesity, irritable bowel syndrome, eczema or atopic dermatitis, and asthma. Non-replicative strains of <i>Bifidobacterium longum</i> (NCC3001 and NCC2705) promote the differentiation of normal human epidermal keratinocytes (NHEKs), inducing a high expression of differentiation markers (keratin —KRT1—, and transglutaminase —TGM1—) and pro-regeneration markers (cathepsins), including β-defensin-1, which plays an important role in modulating the cutaneous immune response. Strains belonging to the genera <i>Bifidobacterium</i> and <i>Lactobacillus</i> can increase tight-junction proteins in NHEKs and enhance barrier function. Bifidobacteria and lactobacilli may be used as prophylactic or therapeutic agents towards enteric pathogens, antibiotic-associated diarrhea, lactose intolerance, ulcerative colitis, irritable bowel syndrome, colorectal cancer, cholesterol reduction, and control of obesity and metabolic disorders. <i>Bifidobacterium bifidum</i> showed an in vitro capability of lowering cholesterol levels thanks to its absorption into the bacterial membrane. Several strains of the species <i>Lactobacillus acidophilus</i>, <i>L. delbrueckii</i> subsp. <i>bulgaricus</i>, <i>L. casei</i>, and <i>L. gasseri</i> led to a reduced amount of serum cholesterol due to their ability to assimilate cholesterol (in vitro). <i>Lactococcus lactis</i> KF147 and <i>Lactobacillus plantarum</i> Lp81 have also been shown to reduce cholesterol levels by 12%. Clarifying the specific health mechanisms of <i>Bifidobacterium</i> and <i>Lactobacillus</i> strains in preventing high-cost pathologies could be useful for delineating effective guidelines for the treatment of infants and adults.https://www.mdpi.com/2076-2607/9/4/836<i>Bidifobacterium longum</i><i>Bidifobacterium bifidum</i>dermatitis syndromeeczemacholesterolSCFAs
spellingShingle Luisa Marras
Michele Caputo
Sonia Bisicchia
Matteo Soato
Giacomo Bertolino
Susanna Vaccaro
Rosanna Inturri
The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia
Microorganisms
<i>Bidifobacterium longum</i>
<i>Bidifobacterium bifidum</i>
dermatitis syndrome
eczema
cholesterol
SCFAs
title The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia
title_full The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia
title_fullStr The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia
title_full_unstemmed The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia
title_short The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia
title_sort role of bifidobacteria in predictive and preventive medicine a focus on eczema and hypercholesterolemia
topic <i>Bidifobacterium longum</i>
<i>Bidifobacterium bifidum</i>
dermatitis syndrome
eczema
cholesterol
SCFAs
url https://www.mdpi.com/2076-2607/9/4/836
work_keys_str_mv AT luisamarras theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT michelecaputo theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT soniabisicchia theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT matteosoato theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT giacomobertolino theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT susannavaccaro theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT rosannainturri theroleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT luisamarras roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT michelecaputo roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT soniabisicchia roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT matteosoato roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT giacomobertolino roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT susannavaccaro roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia
AT rosannainturri roleofbifidobacteriainpredictiveandpreventivemedicineafocusoneczemaandhypercholesterolemia